GelStat Corporation (GSAC)
GelStat Corporation operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Palm City, FL, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $185,394. On trailing twelve-month figures it carries a trailing P/E of -4.57, a net margin of -142.0%. Its beta of 1.64 implies it has historically moved more than the broad market.
GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.
GelStat Corporation is most often compared with the following Healthcare names: